Skip to main content
. 2012 Sep 13;7(9):e45246. doi: 10.1371/journal.pone.0045246

Table 4. ORs comparison between Group 1 (cervical cancer) and Group 3 (HPV negative with no cervical cancer).

Genotype Group 1 (n = 285) Group 3 (n = 318) OR* (95% CI) P OR* (95% CI) P
No. (%) No. (%)
GG 247 (86.7) 274 (86.2) reference 1.007(0.382–2.657) 0.988
GA 30 (10.5) 35 (11.0) 0.932(0.554–1.567) 0.790 0.791(0.321–2.747) 0.908
AA 8 (2.8) 9 (2.8) 0.993(0.376–2.618) 0.988 reference
GG+GA 277 (97.2) 309 (97.2) reference 1.000 (0.380–2.632) 1.000
AA 8 (2.8) 9 (2.8) 1.000(0.380–2.634) 1.000 reference
GA+AA 38 (13.3) 44 (13.8) reference 0.944 (0.591–1.509) 0.811
GG 247 (86.7) 274 (86.2) 1.059(0.663–1.692) 0.811 reference

Note: *Data were calculated by multivariate regression analysis, adjusting for age and smoking status.